Metabolic and cardiovascular outcomes in patients with Cushing’s syndrome of different aetiologies during active disease and 1 year after remission

Body Composition After Endogenous (Cushing's Syndrome) and Exogenous (Rheumatoid Arthritis) Exposure to Glucocorticoids

(2010) E. Resmini et al.   HORMONE AND METABOLIC RESEARCH

Pathophysiology of Dyslipidemia in Cushing’s Syndrome

(2010) Giorgio Arnaldi et al.   NEUROENDOCRINOLOGY

Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome

(2009) María-José Barahona et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation

(2009) Mark S. Cooper et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma

(2009) Susan M. Webb et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline

(2008) Lynnette K. Nieman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM